BioLife Solutions
BLFS
31 hedge funds and large institutions have $10.3M invested in BioLife Solutions in 2017 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 2 closing their positions.
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
175% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 4
40% more capital invested
Capital invested by funds: $7.32M → $10.3M (+$2.93M)
29% more funds holding
Funds holding: 24 → 31 (+7)
2.85% more ownership
Funds ownership: 9.69% → 12.54% (+2.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$976K |
| 2 |
Millennium Management
New York
|
+$947K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$444K |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$261K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$107K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$284K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$200K |
| 3 |
VF
Virtu Financial
New York
|
-$96K |
| 4 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$23.1K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$5.86K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LTFS
26
Ladenburg Thalmann Financial Services
Miami,
Florida
| $2K | +$1.73K | +300 | New |
|
27
Morgan Stanley
New York
| $1K | +$1.06K | +184 | +594% |
|
|
VF
28
Virtu Financial
New York
| – | -$96K | -16,793 | Closed |
|
|
CB
29
Community Bank
Dewitt,
New York
| – | -$1K | -250 | Closed |
|
|
LWA
30
Lowe Wealth Advisors
Columbia,
Maryland
| – | +$12 | +2 | New |
|
|
SIC
31
Salem Investment Counselors
Winston Salem,
North Carolina
| – | +$415 | +72 | New |
|
BLFS Hedge Fund Activity: Q4 2017 in Review
31 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q4 2017, worth a combined $10.3M — up 40% from $7.32M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new BLFS positions and 2 closed out — a net gain of 7 holders — while 11 added to existing stakes and 4 trimmed.
The largest buyer was Essex Investment Management, adding an estimated $976K. The largest seller was Renaissance Technologies, cutting an estimated $284K.
- 31 institutional investors held BioLife Solutions (BLFS) as of Q4 2017, up from 24 in Q3 2017.
- Funds reported $10.3M of BioLife Solutions stock for Q4 2017, up 40% quarter-over-quarter.
- 9 funds opened new BioLife Solutions positions in Q4 2017 and 2 closed out, a net change of +7 holders.
- The largest BioLife Solutions buyer in Q4 2017 was Essex Investment Management, an estimated $976K added.
- The largest BioLife Solutions seller in Q4 2017 was Renaissance Technologies, an estimated $284K sold.
Based on aggregated 13F filings for Q4 2017.